EXEL's shares surge 50% in a year on the back of the strong performance of its lead drug Cabometyx. We are optimistic about ...

These seven blue-chip dividend stocks provide investors a steady stream of passive income and offer promising total return.

I-Mab has begun the new year with a pipeline pivot, pausing work on an asset that Sanofi bought into last year to focus on ...

Bristol-Myers Squibb is trying again to get approval for its checkpoint inhibitor combination of Opdivo and Yervoy in previously-untreated non-small cell lung cancer (NSCLC), which right now is do ...

The Rajasthan health department has set up separate OPD and IPD facilities for Covid, swine flu, and influenza patients. This ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

Al Jazeera’s Moath al-Kahlout, one of the few journalists in northern Gaza, has been to the scene of an Israeli attack. Hamas tells news agencies it has approved a list of 34 captives to be ...

The firm is shifting its resources to fund and expand its Phase I clinical trial of givastomig in CLDN18.2-expressing advanced solid tumor patients.

With new treatments in neurology, and more in development in cardiology and autoimmune diseases, precision medicine is moving beyond cancer and rare disease.

Tarpon Springs, Florida, celebrated Epiphany on Monday, January 6, 2025, a deeply rooted observance in the city's Greek heritage and one of the most significant celebrations in the United States. This ...